2001•Clinical Breast CancerRequires access

Randomized Phase II Trial Comparing Exemestane to Tamoxifen for First-Line Hormonal Therapy of Postmenopausal Patients with Metastatic Breast Cancer

Kavita Maung, Joyce O’Shaughnessy

Open publisher page 3 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Exemestane, Tamoxifen, Breast cancer, Oncology, Hormonal therapy, Randomized controlled trial, Metastatic breast cancer

Back to paper search Browse research topics Original source

Randomized Phase II Trial Comparing Exemestane to Tamoxifen for First-Line Hormonal Therapy of Postmenopausal Patients with Metastatic Breast Cancer — Research Paper | ScholarLens